hiv-infections

Documents about hiv-infections

• A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients#18700ClinicalTrials.gov
• Antigenic Competition in HIV Preventive Vaccines#18704ClinicalTrials.gov
• Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)#18709ClinicalTrials.gov
• Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs#28416ClinicalTrials.gov
• A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59#28426ClinicalTrials.gov
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.#28432ClinicalTrials.gov
• Home HIV Testing for Older Adults in South Africa#28526ClinicalTrials.gov
• Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)#67680ClinicalTrials.gov
• Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults#67694ClinicalTrials.gov
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults#121426ClinicalTrials.gov
• Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection#121427ClinicalTrials.gov
• Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults#121432ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults#121459ClinicalTrials.gov
• Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People#121462ClinicalTrials.gov
• A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3#123530ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States#123542ClinicalTrials.gov
• Tuberculosis Prevention for HIV Infected Adults#325320ClinicalTrials.gov
• Long-Term Effects of HIV Exposure and Infection in Children#329574ClinicalTrials.gov
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems#332791ClinicalTrials.gov
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose#346991ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers#349998ClinicalTrials.gov
• A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults#350000ClinicalTrials.gov
• Dendritic Cell Vaccine in HIV-1 Infection#350007ClinicalTrials.gov
• A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine#350013ClinicalTrials.gov
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)#353320ClinicalTrials.gov
• "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection#353321ClinicalTrials.gov
• A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers#356549ClinicalTrials.gov
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults#366644ClinicalTrials.gov
• Data Sheet 1_Nutrition education has a positive impact on nutritional knowledge, food consumption and body composition in PLHIV: a randomized clinical trial.xlsx#202140Figshare
• Supplementary file 1_Nutrition education has a positive impact on nutritional knowledge, food consumption and body composition in PLHIV: a randomized clinical trial.pdf#202141Figshare

Related topics